Velarion · Company Intelligence
CompBrief
Fiscal year 2025

Michael Henderson — FY2025 total compensation $1,291,500

Michael Henderson is Chief Executive Officer of Apogee Therapeutics, Inc. (APGE). The company reported total compensation of $1,291,500 for fiscal year 2025.

01

Fiscal year 2025 compensation

Salary$700,000
Bonus$0
Stock awards$0
Option awards$0
Non-equity incentive plan$591,500
Pension and non-qualified deferred compensation$0
All other compensation$0
Total$1,291,500

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.

Cited to the compensation disclosure Apogee Therapeutics, Inc. filed April 24, 2026, accession 0001193125-26-177342.

02

History — every fiscal year held

Fiscal yearRoleSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
FY2025Chief Executive Officer$700,000$0$0$0$591,500$0$0$1,291,500
FY2024Chief Executive Officer$661,500$0$0$12,000,444$545,738$0$0$13,207,682
FY2023Chief Executive Officer$564,833$606,375$0$7,500,000$0$0$0$8,671,208

Totals as disclosed in each year's own compensation disclosure for Apogee Therapeutics, Inc..

03

Peer context

Peer-group chief executive median$9,512,640
Difference from that median$-8,221,140
Percentile within the disclosed peer group1st
Peers with a disclosed figure15

Medians and percentiles are computed across the peer group Apogee Therapeutics, Inc. discloses in its own compensation disclosure.

04

The other named executive officers of Apogee Therapeutics, Inc.

Named executive officerRoleFY2025 total
Michael Henderson this pageChief Executive Officer$1,291,500
Carl DambkowskiChief Medical Officer$855,900

The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Apogee Therapeutics, Inc. compensation brief.

05

The company page

Michael Henderson's compensation sits inside Apogee Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.

The Apogee Therapeutics, Inc. (APGE) compensation brief